XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income (loss) attributable to Agrify Corporation $ 1,264 $ (17,132)
Adjustments to reconcile net income (loss) attributable to Agrify Corporation to net cash used in operating activities:    
Depreciation and amortization 782 938
Amortization of debt discount 70
Amortization of issuance costs 24
Amortization of right of use assets 290 505
Stock based compensation expense 571 1,611
Change in fair value of warrant liabilities 404 (1,624)
Loss on extinguishment of long-term debt, net 4,631
Change in provision for credit losses, net 346 (542)
Change in inventory reserves (1,092) (337)
(Gain) loss on disposal of property and equipment (9) 5
Gain on early termination of lease (39)
Gain on settlement of contingent liabilities (5,935)
Change in accrued acquisition liabilities due to issuance of held-back shares (2,180)
Loss attributable to non-controlling interests (2)
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 201 264
Inventory 1,759 3,030
Prepaid expenses and other current assets 2,686 739
Other non-current assets 44 170
Accounts payable (2,792) 1,237
Accrued expenses and other current liabilities (669) (4,261)
Operating lease liabilities (275) (441)
Contract liabilities (172) (519)
Net cash and cash equivalents used in operating activities (4,816) (11,634)
Cash flows from investing activities:    
Purchases of property and equipment (4) (60)
Proceeds from disposal of property and equipment 10 5
Proceeds from sale of marketable securities 10,456
Issuance of loans receivable (591)
Proceeds from repayment of loans receivable 330 1,548
Net cash and cash equivalents provided by investing activities 336 11,358
Cash flows from financing activities:    
Proceeds from Issuance of Common Stock through an S-1 and Prefunded Warrants offering 2,123
Proceeds from issuance of Common Stock through an at the market offering, net of fees 1,545
Proceeds from Employee Stock Purchase Plan Shares 25
Proceeds from exercise of S-1 Prefunded Warrants 4
Proceeds from issuance of related party notes 2,294
Repayments of notes payable, other (71)
Repayment of debt in private placement (10,307)
Payments on other financing loans (1) (2)
Payments on insurance financing loans (317) (999)
Payments of financing leases (64)
Net cash and cash equivalents provided by (used in) financing activities 4,103 (9,873)
Net decrease in cash and cash equivalents (377) (10,149)
Cash and cash equivalents at the beginning of period 430 10,457
Cash and cash equivalents at the end of period 53 308
Supplemental disclosures    
Cash paid for interest 95 64
Supplemental disclosures of non-cash flow information    
Cashless exercise of High-Trail warrants 3
Financing of prepaid insurance 17 1,820
Transfer of loans receivable from noncurrent to current 1,295
Transfer of property and equipment to inventory 33
Reclassification of liability classified prefunded warrants to equity 6,791
Conversion of related party debt into warrants 10,044
Accrued interest consolidated into related party debt 364
Contribution from troubled debt restructuring with related party 676
Consolidation of related party debt principal 3,799
Conversion of convertible notes into equity 1,731 3,160
Non-cash amounts of lease liabilities arising from obtaining right-of-use assets $ 654